David Beatty
J. David Beatty, M.D.

J. David Beatty, M.D.

J. David Beatty, M.D.
Specialty

Breast Surgery, Breast-Cancer Surgery

Clinical Interests / Special Procedures Performed

Balloon Catheter Based Breast Brachytherapy, Bloodless Breast Surgery, Bloodless Surgery, Breast Aspiration, Breast Biopsy, Breast Cancer, Breast Disorders, Breast Imaging, Breast Surgery, Cancer Institute, Cancer Surgery, Clinical Research & Educ., Clinical Trials, Mammosite, Oncologic Surgery, Sentinel Lymph Node Biopsy, Ultrasound-Guided Biopsy

  • Accepting Children: No
  • Accepting New Patients: Yes
  • Accepting Medicare: Yes
  • Accepting Medicaid/DSHS: Yes
Payment Methods Accepted:

Medicare, Medicaid/DSHS, Bill Insurance, VISA, Master Card, Cash, Check, Payment Plan, American Express, Billing Service, Discover Card, Money Order

Insurance Accepted:

Contact this office for accepted insurance plans.

Additional Information:

Education: Dr. Beatty received biological, medical and surgical training at the University of Toronto complemented by postgraduate training in research and oncology in Canada (Princess Margaret Hospital, Toronto; Manitoba Cancer Treatment and Research Foundation, University of Manitoba, Winnipeg), the United Kingdom (Middlesex Hospital Medical School, London) and the United States (Medical College of Virginia, Richmond, VA).

Background: Since 1978, Dr. Beatty’s clinical activities have focused on cancer care, research and education. He has held academic and administrative appointments at a number of universities (Manitoba, California, Toronto, Vermont) and has been the principal investigator for a number of translational research grants from the National Cancer Institute. At the City of Hope National Cancer Center, he established and led the surgical oncology training program. Administrative positions have included Executive Director of the National Cancer Institute of Canada (1991-1996) where he over-saw the peer review system for distribution of research funds, was instrumental in the establishment of the Canadian Breast Cancer Research Initiative and the Center for Behavioral Research and Program Evaluation, and contributed to the establishment of the Canadian Genome Analysis and Technology Program. In 2004, he joined the Swedish Cancer Institute in a leadership capacity.

Special Interests: Over the past 15 years, Dr. Beatty’s practice and academic activities have been focused on breast cancer. His clinical practice emphasizes management of patients with complex breast care and breast cancer problems. His surgical expertise includes breast biopsy, minimally invasive technology, ultrasound guided procedures, sentinel node localization and biopsy, breast conserving surgery, oncoplastic surgery, axillary preserving surgery, image guided surgery, balloon catheter placement for partial breast irradiation, bloodless surgery, and integration of surgery and multidisciplinary care. He leads and participates in a variety of innovative pilot and collaborative research trials focused on developing new technology, translating new technology into optimal clinical practice and standardizing breast cancer quality of care evaluation. He is actively involved in the general surgery residency training program at Swedish Medical Center and is a Joint Full Member of the Public Health Sciences Division at Fred Hutchinson Cancer Research Center in Seattle.

Philosophy of Care: Dr. Beatty believes in excellent care for all patients, patient participation in individualized decision-making, compassion and commitment.

________________________________________

CURRENT POSITIONS:

2009 – Present   Joint Full Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2008 – Present   Medical Director, First Hill Breast Surgery Clinic, Swedish Cancer Institute, Seattle, WA
2008 – Present   Medical Director, Research and Education, Breast Cancer Program, Swedish Cancer Institute, Seattle, WA
________________________________________

PREVIOUS POSITIONS AND FACULTY APPOINTMENTS:

2003 - 2008   Program Leader, Comprehensive Breast Cancer Program and Surgeon Swedish Cancer Institute, Swedish Medical Center, Seattle, WA
1999 - 2003   Professor (tenured), Department of Surgery, College of Medicine, University of Vermont and Attending Surgeon, Fletcher Allen Health Care, Burlington, VT; Chairman, Division of Surgical Oncology, University of Vermont/Fletcher Allen Health Care; Director, Breast Care Center, Fletcher Allen Health Care/University of Vermont; Head, White Surgical Team, Department of Surgery, Fletcher Allen Health Care
2001 - 2003   Adjunct Professor, Department of Medicine, College of Medicine, University of Vermont
1991 - 1999   Professor, Department of Surgery, Faculty of Medicine, University of Toronto
1996 - 1999   Member, Institute of Medical Science, Faculty of Medicine, University of Toronto
1996 - 1998   Head, Department of Surgery, Sunnybrook Health Science Centre and Surgical Oncologist, Toronto Sunnybrook Regional Cancer Centre, Toronto, Canada
1991 - 1996   Executive Director, National Cancer Institute of Canada, Toronto, Canada
1988 - 1991   Vice-Chair, Division of Surgery, City of Hope National Medical Center, Los Angeles, CA
1981 1991   Surgeon, Department of General Oncologic Surgery and Coordinator, Team B Surgical Service, City of Hope National Medical Center, Los Angeles, CA
1980 1981   Chief, Surgical Oncology & Thoracic Surgery Service, Health Sciences Center, Winnipeg
1978 1981   Chairman, Head and Neck Cancer Consultation Conference and Surgeon, Manitoba; Cancer Treatment and Research Foundation; Surgeon Health Sciences Center and Winnipeg Clinic, Winnipeg, Manitoba, Canada
________________________________________

AWARDS:

2011   Outstanding State Chair; Commission on Cancer and American College of Surgeons
2004 – 2005 T  eacher of the Year – Surgical Residents, Swedish Medical Center
1996   The First Canada - U.S. Breast Cancer Advocacy Conference Award for “Innovative Approach by a Foundation or Charity” in the fight against breast cancer.
1995   The Doctors Margaret and Norman Gosse Lectureship in Cancer - Dalhousie University, Halifax, Nova Scotia
1991   Spirit of Hope Award - City of Hope National Medical Center
1985 1986   David W. Christopher Research Fellowship - City of Hope National Medical Center
1985 1986   Peter Gold Research Fellowship - City of Hope National Medical Center
1984 1985   Arthur R. Mehr Research Fellowship - City of Hope National Medical Center
1983 1984   Richard B. Stone Research Fellowship - City of Hope National Medical Center
1982 - 1983   John J. Faltis Research Fellowship - City of Hope National Medical Center
1977 1978   R.S. McLaughlin Fellowship - McLaughlin Foundation, Canada
1975   Gordon Richards Fellowship - Ontario Division, Canadian Cancer Society
1971   1972 Astor Fellowship - Middlesex Hospital Medical School, London, England
1970   Honour Award (Undergraduate) - Faculty of Medicine, University of Toronto
1970   CIBA Award (Undergraduate) - Faculty of Medicine, University of Toronto

________________________________________

PROFESSIONAL AFFILIATIONS:

American Association for Cancer Research (AACR)
American College of Surgeons (FACS) (Fellow)
American Society of Breast Disease (ASBD)
American Society of Breast Surgeons (ASBS)
American Society of Clinical Oncology (ASCO)
Christian Medical and Dental Associations (CMDA)
National Consortium of Breast Centers (NCBC)
National Surgical Adjuvant Breast and Bowel Project (NSABP)
North Pacific Surgical Association (NPSA)
Pacific Coast Surgical Association (PCSA)
Puget Sound Oncology Consortium (PSOC)
Royal College of Physicians and Surgeons of Canada (FRCSC) (Fellow)
Seattle Surgical Society
Society of Surgical Oncology (SSO)
South West Oncology Group (SWOG)
Washington Chapter, American College of Surgeons

Medical School

University of Toronto

Residency

University of Toronto

Fellowship(s)

Medical/Radiation Oncology (Princess Margaret Hosp, U Toronto), Surgical Pathology (Middlesex Hospital, U London, GB), Tumor Immunology (Manitoba Cancer Foundation, U Manitoba), Surgical Oncology (Medical College of Virginia, VCU)

Board Certifications

Royal College of Physicians and Surgeons of Canada, General Surgery 1975American College of Surgeons, General Surgery, 1984, 1999

Additional Information:

Education: Dr. Beatty received biological, medical and surgical training at the University of Toronto complemented by postgraduate training in research and oncology in Canada (Princess Margaret Hospital, Toronto; Manitoba Cancer Treatment and Research Foundation, University of Manitoba, Winnipeg), the United Kingdom (Middlesex Hospital Medical School, London) and the United States (Medical College of Virginia, Richmond, VA).

Background: Since 1978, Dr. Beatty’s clinical activities have focused on cancer care, research and education. He has held academic and administrative appointments at a number of universities (Manitoba, California, Toronto, Vermont) and has been the principal investigator for a number of translational research grants from the National Cancer Institute. At the City of Hope National Cancer Center, he established and led the surgical oncology training program. Administrative positions have included Executive Director of the National Cancer Institute of Canada (1991-1996) where he over-saw the peer review system for distribution of research funds, was instrumental in the establishment of the Canadian Breast Cancer Research Initiative and the Center for Behavioral Research and Program Evaluation, and contributed to the establishment of the Canadian Genome Analysis and Technology Program. In 2004, he joined the Swedish Cancer Institute in a leadership capacity.

Special Interests: Over the past 15 years, Dr. Beatty’s practice and academic activities have been focused on breast cancer. His clinical practice emphasizes management of patients with complex breast care and breast cancer problems. His surgical expertise includes breast biopsy, minimally invasive technology, ultrasound guided procedures, sentinel node localization and biopsy, breast conserving surgery, oncoplastic surgery, axillary preserving surgery, image guided surgery, balloon catheter placement for partial breast irradiation, bloodless surgery, and integration of surgery and multidisciplinary care. He leads and participates in a variety of innovative pilot and collaborative research trials focused on developing new technology, translating new technology into optimal clinical practice and standardizing breast cancer quality of care evaluation. He is actively involved in the general surgery residency training program at Swedish Medical Center and is a Joint Full Member of the Public Health Sciences Division at Fred Hutchinson Cancer Research Center in Seattle.

Philosophy of Care: Dr. Beatty believes in excellent care for all patients, patient participation in individualized decision-making, compassion and commitment.

________________________________________

CURRENT POSITIONS:

2009 – Present   Joint Full Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2008 – Present   Medical Director, First Hill Breast Surgery Clinic, Swedish Cancer Institute, Seattle, WA
2008 – Present   Medical Director, Research and Education, Breast Cancer Program, Swedish Cancer Institute, Seattle, WA
________________________________________

PREVIOUS POSITIONS AND FACULTY APPOINTMENTS:

2003 - 2008   Program Leader, Comprehensive Breast Cancer Program and Surgeon Swedish Cancer Institute, Swedish Medical Center, Seattle, WA
1999 - 2003   Professor (tenured), Department of Surgery, College of Medicine, University of Vermont and Attending Surgeon, Fletcher Allen Health Care, Burlington, VT; Chairman, Division of Surgical Oncology, University of Vermont/Fletcher Allen Health Care; Director, Breast Care Center, Fletcher Allen Health Care/University of Vermont; Head, White Surgical Team, Department of Surgery, Fletcher Allen Health Care
2001 - 2003   Adjunct Professor, Department of Medicine, College of Medicine, University of Vermont
1991 - 1999   Professor, Department of Surgery, Faculty of Medicine, University of Toronto
1996 - 1999   Member, Institute of Medical Science, Faculty of Medicine, University of Toronto
1996 - 1998   Head, Department of Surgery, Sunnybrook Health Science Centre and Surgical Oncologist, Toronto Sunnybrook Regional Cancer Centre, Toronto, Canada
1991 - 1996   Executive Director, National Cancer Institute of Canada, Toronto, Canada
1988 - 1991   Vice-Chair, Division of Surgery, City of Hope National Medical Center, Los Angeles, CA
1981 1991   Surgeon, Department of General Oncologic Surgery and Coordinator, Team B Surgical Service, City of Hope National Medical Center, Los Angeles, CA
1980 1981   Chief, Surgical Oncology & Thoracic Surgery Service, Health Sciences Center, Winnipeg
1978 1981   Chairman, Head and Neck Cancer Consultation Conference and Surgeon, Manitoba; Cancer Treatment and Research Foundation; Surgeon Health Sciences Center and Winnipeg Clinic, Winnipeg, Manitoba, Canada
________________________________________

AWARDS:

2011   Outstanding State Chair; Commission on Cancer and American College of Surgeons
2004 – 2005 T  eacher of the Year – Surgical Residents, Swedish Medical Center
1996   The First Canada - U.S. Breast Cancer Advocacy Conference Award for “Innovative Approach by a Foundation or Charity” in the fight against breast cancer.
1995   The Doctors Margaret and Norman Gosse Lectureship in Cancer - Dalhousie University, Halifax, Nova Scotia
1991   Spirit of Hope Award - City of Hope National Medical Center
1985 1986   David W. Christopher Research Fellowship - City of Hope National Medical Center
1985 1986   Peter Gold Research Fellowship - City of Hope National Medical Center
1984 1985   Arthur R. Mehr Research Fellowship - City of Hope National Medical Center
1983 1984   Richard B. Stone Research Fellowship - City of Hope National Medical Center
1982 - 1983   John J. Faltis Research Fellowship - City of Hope National Medical Center
1977 1978   R.S. McLaughlin Fellowship - McLaughlin Foundation, Canada
1975   Gordon Richards Fellowship - Ontario Division, Canadian Cancer Society
1971   1972 Astor Fellowship - Middlesex Hospital Medical School, London, England
1970   Honour Award (Undergraduate) - Faculty of Medicine, University of Toronto
1970   CIBA Award (Undergraduate) - Faculty of Medicine, University of Toronto

________________________________________

PROFESSIONAL AFFILIATIONS:

American Association for Cancer Research (AACR)
American College of Surgeons (FACS) (Fellow)
American Society of Breast Disease (ASBD)
American Society of Breast Surgeons (ASBS)
American Society of Clinical Oncology (ASCO)
Christian Medical and Dental Associations (CMDA)
National Consortium of Breast Centers (NCBC)
National Surgical Adjuvant Breast and Bowel Project (NSABP)
North Pacific Surgical Association (NPSA)
Pacific Coast Surgical Association (PCSA)
Puget Sound Oncology Consortium (PSOC)
Royal College of Physicians and Surgeons of Canada (FRCSC) (Fellow)
Seattle Surgical Society
Society of Surgical Oncology (SSO)
South West Oncology Group (SWOG)
Washington Chapter, American College of Surgeons

Dr. Beatty has a longstanding record of translational and clinical research, and research administration. He maintains a clinical surgical practice in breast cancer and leads the clinical research activities in breast cancer at the SCI. These studies have included assessment of imaging techniques, surgical care and multidiciplinary care of breast cancer. Completed studies include breast imaging by magnetic resonance (MRI) and positron emission mammography (PEM), metaplastic breast cancer, micro and macrometastasis in sentinel nodes, neoadjuvant chemotherapy, post-mastectomy irradiation, and quality assessment of breast cancer care.

He has also taken the principal responsibility in breast cancer for the interface between the SCI and the fundamental research activities in breast cancer by Dr. Nicole Urban’s group at the Fred Hutchinson Cancer research Center. He has been involved in research subject recruitment, study design, interpretation of results and reports. These studies have reported a 50-gene observation that some normal breast tissue has a profile similar to a selected population of breast cancer tissue. Current studies are exploring the potential to identify breast cancer patients with increased risk of subsequent 2nd breast cancer based upon the gene profile of their normal or atypical breast tissue which in turn could have an impact upon subsequent clinical decision-making. The group is also exploring the relationship significance of erythropoietin receptors in breast cancer patients who have received adjuvant chemotherapy follow breast surgery.

________________________________________

CLINICAL TRIALS:

Dr. Beatty is the lead investigator for the following clinical trials currently available at the Swedish Cancer Institute:

Clinical Value of Pre-Surgery Positron Emission Mammography (PEM) in Patients with Newly Diagnosed Breast Cancer

________________________________________

PUBLICATIONS (SELECTED):

Sanguedolce F, Liatsikos E, Verze P, Hruby S, Breda A, Beatty JD, Knoll T; EAU Young Academic Urologists Group, Arnhem, The Netherlands. Use of flexible ureteroscopy in the clinical practice for the treatment of renal stones: results from a large European survey conducted by the EAU Young Academic Urologists-Working Party on Endourology and Urolithiasis. Urolithiasis. 2014 Mar 28.
 
Phillips M, Beatty JD, Cataneo RN, Huston J, Kaplan PD, Lalisang RI, Lambin P, Lobbes MB, Mundada M, Pappas N, Patel U. Rapid point-of-care breath test for biomarkers of breast cancer and abnormal mammograms. PLoS One. 2014 Mar 5;9(3):e90226.
 
Wang CL, Eissa MJ, Rogers JV, Aravkin AY, Porter BA, Beatty JD. (18)F-FDG PET/CT-positive internal mammary lymph nodes: pathologic correlation by ultrasound-guided fine-needle aspiration and assessment of associated risk factors. AJR Am J Roentgenol. 2013 May;200(5):1138-44.
 
Macdonald LR, Wang CL, Eissa M, Haseley D, Kelly MM, Liu F, Parikh JR, Beatty JD, Rogers JV. Positron emission mammography (PEM): effect of activity concentration, object size, and object contrast on phantom lesion detection. Med Phys. 2012 Oct;39(10):6499-508.

Wang CL, Macdonald LR, Rogers JV, Aravkin A, Haseley DR, Beatty JD. Positron Emission Mammography: Correlation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status and 18F-FDG. Am J Roentgenol. 2011 Aug;1 97(2):W247-55. PMID21785049.

Dooley WC, Algan O, Dowlatshahi K, Francescatti D, Tito E, Beatty JD, Lerner AG, Ballard B, Boolbol SK. Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer.

Taras AR, Thorpe JD, Morris AD, Atwood M, Lowe KA, Beatty JD. Second Place Tie Residents' Competition: Irradiation Effect After Mastectomy on Breast Cancer Recurrence in Patients Presenting with Locally Advanced Disease. Am J Surg. 2011 May; 201(5):603-7. PMID 21545907.

Beatty JD, Adachi M, Bonham C, Atwood M, Potts MS, Hafterson JL, Aye RW. Utilization of Cancer Registry Data for Monitoring Quality of Care. Am J Surg. 2011 May; 201(5):640-4. PMID 21545915.

Schummer M, Beatty JD, Urban N. Breast Cancer Genomics: Normal Tissue and Cancer Markers. Ann N Y Acad Sci. 2010 Oct; 1210:78-85. PMID 20973801.

Beatty JD. Start by Decreasing Unnecessary Ppostmastectomy Irradiation. Arch Surg. 2010 Sep; 145(9):878-9. PMID 20873008.

Precht LM, Lowe KA, Atwood M, Beatty JD. Neoadjuvant Chemotherapy of Breast Cancer: Tumor Markers as Predictors of Pathologic Response, Recurrence, and Survival. Breast J. 2010 Jul; 16(4):362-8. PMID 20443786.

Taras AR, Hendrickson NA, Lowe KA, Atwood M, Beatty JD. Recurrence Rates in Breast Cancer Patients with False-Negative Intraoperative Evaluation of Sentinel Lymph Nodes. Am J Surg. 2010 May; 199(5):625-8. PMID 20466106.

Schummer M, Green A, Beatty JD, Karlan BY, Karlan S, Gross J, Thornton S, McIntosh M, Urban N. Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection. PLoS One. 2010 Feb 9; 5(2):e9122. PMID 20161755.

Beatty JD, Precht LM, Lowe K, Atwood M. Axillary-Conserving Surgery is Facilitated by Neoadjuvant Chemotherapy of Breast Cancer. Am J Surg. 2009 May; 197(5):637-41; discussion 641-2. PMID 19321159.

Taras AR, Hendrickson NA, Pugliese MS, Lowe KA, Atwood M, Beatty JD. Intraoperative Evaluation of Sentinel Lymph Nodes in Invasive Lobular Carcinoma of the Breast. Am J Surg. 2009 May; 197(5):643-6; discussion 646-7. PMID 19393357.

Pugliese MS, Beatty JD, Tickman RJ, Allison KH, Atwood MK, Szymonifka J, Arthurs ZM, Huynh PP, Dawson JH. Impact and Outcomes of Routine Microstaging of Sentinel Lymph Nodes in Breast Cancer: Significance of the pN0(i+) and pN1mi Categories. Ann Surg Oncol. 2009, Jan; 16(1):113-20. PMID 18949520.

Beatty JD, Rees J, Atwood M, Pugliese M, Bolejack V. Standardized Evaluation of Regional and Institutional Breast Cancer Outcomes. Am J Surg. 2008 May; 195(5):636-40. PMID 18374891.

Beatty JD, Porter BA. Contrast-Enhanced Breast Magnetic Resonance Imaging: The Surgical Perspective. Am J Surg. 2007 May; 193(5):600-5. PMID 17434364.

Pugliese MS, Tickman R, Wang NP, Atwood M, Beatty JD. The Utility of Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer. Ann Surg Oncol. 2007 Mar; 14(3):1024-30. PMID 17195910.

Wong JYC, Chu DZJ, Yamauchi D, Odom-Maryon TL, Williams LE, Liu A, Esteban JM, Wu AM, Primus FJ, Beatty JD, Shively JE. Raubitschek AA. A Dose Escalation Trial Evaluating 111-Indium Labeled Anti-CEA Chimeric Monoclonal Antibody (cT84.66) in Pre-surgical Patients with Colorectal Cancer., J Nucl Med 39:2097-2104, 1998. PMID 9867150.

Kuhn JA, Beatty BG, Wong JYC, Esteban JM, Wanek PM, Wall FJ, Buras RR, Williams LE, Beatty JD. Interferon Enhancement of Radioimmunotherapy for Colon Cancer. Cancer Res 51:2335-2339. 1991. PMID 1901760.

Beatty JD, Williams LE, Yamauchi D, Morton BA, Beatty BG, Merchant B, Paxton RJ, Shively JE. Presurgical Imaging with Indium Labeled Anti-CEA for Colon Cancer Staging. Cancer Res (Suppl) 50:922s-926s.1990. PMID 2297742.

Beatty BG, O'Connor-Tressel M, Do T, Beatty JD. Mechanism of Decreasing Liver Uptake of 111In-labeled MAB by Specific Antibody Pretreatment in Tumour Bearing Mice. Cancer Res (Suppl) 50:846s-851s.1990. PMID 2297732.

Beatty JD, Beatty BG, O'Connor-Tressel M, Do T. Mechanisms of Tissue Uptake and Metabolism of Radiolabeled Antibody. Cancer Res (Suppl) 50:840s-845s.1990.PMID 2297731

Beatty BG, Beatty JD, O'Connor-Tressel M, Williams LE, Paxton RJ, Shively JE. Effect of Large Dose Specific Antibody Pretreatment on Liver Uptake of 111-In-Labeled Anti-CEA Monoclonal Antibody in Nude Mice Bearing Human Colon Cancer Xenografts. Cancer Res 49:1587-1594. 1989. PMID2924309.

Beatty JD, Beatty BG, Vlahos WG. Measurement of Monoclonal Antibody Affi¬nity by Non Competitive Enzyme Immunoassay. J Immunol Methods 100:173 179. 1987. PMID 2439600.

Beatty JD, Beatty BG, Vlahos WG, Hill LR. Method of Analysis of Non-Competitive Enzyme Immuno- assays for Antibody Quantification. J Immunol Methods 100:161 172.1987. PMID 3298436.

Beatty JD, Duda RB, Williams LE, Sheibani K, Paxton RJ, Beatty BG, Philben VJ, Werner JL, Shively JE, Vlahos WG, Kokal WA, Riihimaki DU, Terz JJ, Wagman LD. Preoperative Imaging of Colorectal Carcinoma with Indium 111 Labeled Anti-CEA Monoclonal Antibody. Cancer Res 46:6494 6502. 1986. PMID 3779657.

Offices

True Family Women's Cancer Center
1221 Madison St.
6th Floor
Seattle, WA 98104
Phone: 206-215-6400

Map & Directions

Physicians: Is this your profile? Click here for info

Affiliations

This provider is affiliated with: